Nova Eye Medical Limited
ASX:EYE.AX
Overview | Financials
Company Name | Nova Eye Medical Limited |
Symbol | EYE.AX |
Currency | AUD |
Price | 0.175 |
Market Cap | 40,085,675 |
Dividend Yield | 0% |
52-week-range | 0.115 - 0.325 |
Industry | Medical Devices |
Sector | Healthcare |
CEO | Mr. Victor Previn B.E., B.Eng |
Website | https://nova-eye.com |
An error occurred while fetching data.
About Nova Eye Medical Limited
Nova Eye Medical Limited designs, develops, distributes, markets, sells, and services surgical devices for the treatment of glaucoma. The company offers iTrack, a surgical system for the reduction in intraocular pressure (IOP) in adult patients with open-angle glaucoma; iTrack Advance, a natural ocular drainage system; Molteno3, a glaucoma drainage device
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD